Deciphera Pharmaceuticals
The Director of Market Access Pricing & Analytics leads strategies around pricing, contracting, and reimbursement within the US healthcare market. The role involves advanced data analysis, financial modeling, and cross-functional collaboration to support business growth and patient access in the pharmaceutical and biotech sectors.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
93% above the average for this role
Associate Director, Pricing Strategy & Access Analytics
Amylyx Pharmaceuticals
Director, Market Access Deal Analytics
Axsome Therapeutics
Vice President, US Market Access
Alfasigma
Director / Lead Pricing and Contracting - Biologics
drreddyslaboratorieslimited.com
Intern - Value, Access & Pricing (VAP) Analytics
City of London, Ontario
Senior Manager, Pricing Operations
Crinetics Pharmaceuticals